A 2025 Endocrine Society presentation put the figure near 40 percent for semaglutide, and a 2024 Circulation clinical primer reported a similar range across the drug class
Potential side effects include nausea, gastrointestinal upset, and, in rare cases, pancreatitis or gallbladder issues
Thanksgiving is just around the corner, and with it comes the annual feast of turkey, mashed potatoes, and Aunt Lindas famous pumpkin pie
Birkenfeld emphasizes that a decrease in muscle mass in the context of successful weight loss is usually a physiological adaptation: "Greater weight loss is usually accompanied by an adjustment in muscle mass [...]
Mounjaro for Type 2 Diabetes: A New Era in Blood Sugar Control Although Mounjaro is now widely used for weight management, it was originally developed and approved for type 2 diabetes
, ( , )